DSKYF:OTCMKTS
Daiichi Sankyo Co Ltd
15,95 $
arrow_downward
−1,24%(−0,20) 1D
9. okt., 16:00:00 GMT -4 · USD
search
Vsi simboli
| Simbol | Cena | Sprememba | Odstotna sprememba |
|---|
insights_autoGeneriranje najpomembnejših vpogledov za DSKYF …
Odpri
16,88 $
Visoka
16,88 $
Nizka
15,95 $
Tržna kapitalizacija
30,95 mrd.
Povprečni promet
2,62 tis.
Promet
3,41 tis.
52-tedenski najvišji tečaj
29,10 $
52-tedenski najnižji tečaj
13,85 $
Beta
−1,13
Št. izdanih delnic
1,86 mrd.
Št. zaposlenih
20 tis.
Odpri
16,88 $
Visoka
16,88 $
Nizka
15,95 $
Tržna kapitalizacija
30,95 mrd.
Povprečni promet
2,62 tis.
Promet
3,41 tis.
52-tedenski najvišji tečaj
29,10 $
52-tedenski najnižji tečaj
13,85 $
Beta
−1,13
Št. izdanih delnic
1,86 mrd.
Št. zaposlenih
20 tis.
Novice
Iz spletnih virov in novičarskih partnerjev
AD HOC NEWS
·
pred 3 dnevi
Daiichi Sankyo stock gets Citi Buy rating with JPY 4,700 target
Profil
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent.
Daiichi Sankyo, Inc. began operating in the U.S. in 2006. It is the U.S. subsidiary of Daiichi Sankyo Company, Limited, and a member of the Daiichi Sankyo Group. The organization, which includes U.S. commercial operations and global clinical development, is headquartered in Basking Ridge, New Jersey.
Daiichi Sankyo Europe, GmbH, the European subsidiary, is headquartered in Munich, Germany. The organization is responsible for development and manufacturing for 12 European countries.
Daiichi Sankyo Company, Limited is a full member of the European Federation of Pharmaceutical Industries and Associations and of the International Federation of Pharmaceutical Manufacturers and Associations. Wikipedia
Vizitka: Daiichi Sankyo Co Ltd
Generalni direktorHiroyuki Okuzawa
Št. zaposlenih20,2 tis.
Ustanovljeno28. sep. 2005
SedežChuo City, Tokio, Japonska
Sektor-
Spletno mestodaiichisankyo.co.jp